Last updated: April 8, 2024
Sponsor: National Cancer Center, China
Overall Status: Active - Recruiting
Phase
N/A
Condition
Colorectal Cancer
Colon Cancer
Treatment
Laparoscopic right hemicolectomy with transrectal specimen extraction
Clinical Study ID
NCT06362902
NOSES-VIII B
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Biopsy proven colon carcinoma;
- Imaging diagnosis of T1-3 colon cancer;
- The tumor located in the cecum, ascending colon, or colonic hepatic flexure;
- Maximal tumor diameter ≤5 cm;
- Body mass index (BMI) ≤30 kg/m2;
- Written informed consent;
Exclusion
Exclusion Criteria:
- Complete intestinal obstruction;
- Hepatitis activity and peripheral neuropathy (such as peripheral neuritis, pseudomeningitis, motor neuritis, and sensory impairment);
- Significant organ dysfunction or other significant diseases, including clinicallyrelevant coronary artery disease, cardiovascular disease, or myocardial infarctionwithin the 12 months before enrollment; severe neurological or psychiatric history;severe infection; active disseminated intravascular coagulation;
- Pregnancy or breastfeeding;
- Alcohol abuse or drug addiction;
- Concurrent uncontrolled medical condition;
Study Design
Total Participants: 37
Treatment Group(s): 1
Primary Treatment: Laparoscopic right hemicolectomy with transrectal specimen extraction
Phase:
Study Start date:
March 01, 2024
Estimated Completion Date:
September 01, 2025
Study Description
Connect with a study center
National Cancer Center
Beijing, Beijing 100000
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.